Quantcast

World Adult Vaccines Market Analysis and 2020 Forecasts

April 13, 2014

RnRMarketResearch.com adds “Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines – Worldwide Analysis” to its store.

DALLAS, April 13, 2014 /PRNewswire-iReach/ — World Adult Vaccines Market – Market Overview

For much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles, and other diseases. While Pediatric Vaccines are an important market, it is now adults who are fueling growth of vaccine products. The world adult vaccines market is expected to nearly double by 2020 from the current figure of 2012.

(Photo: http://photos.prnewswire.com/prnh/20140413/MN02533)

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine preventable diseases and their resulting deaths are now rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry.

This report provides a comprehensive assessment of the fast-evolving, high-growth of World Adult Vaccines Landscape. This 222 page report with 142 Figures and 15 Tables studies: 9 Adult Vaccines Market, 5 Companies Adult Vaccines Sales. In total 28 Adult Vaccines have been researched for this report. This report is broadly divided into 11 chapters.

Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=157419 .

Adult Vaccines Market & Forecast data (2007 – 2020) covered in the report are as follows:

1. Influenza

2. Cervical Cancer/ HPV

3. Hepatitis

4. Zoster Shingles

5. Pneumococcal

6. Measles, Mumps, Rubella and Varicella (MMRV)

7. Meningococcal

8. Diphtheria, Tetanus, Pertussis (DTP)

9. Travel and Miscellaneous

Companies’ Adult Vaccines Sales Share and Forecast data (2007 – 2020) covered in the report

1. GlaxoSmithKline (GSK)

2. Sanofi Pasteur

3. Merck

4. Novartis

5. Pfizer

6. Others

(Chapter 1): Executive Summary

(Chapter 2): This Chapter is divided into 2 parts

A. Adult Vaccines Market and Forecast data from 2007 to 2020

B. Adult Vaccinated Number and Forecast from 2007 to 2020

(Chapter 3): This chapter is divided into 3 parts

A. Provides market share (percentage) of Adult Vaccines in the above mentioned vaccines

B. Provides market share (percentage) of Adult Vaccinated in the above mentioned vaccines

C. Provides above mentioned companies market share in Adult vaccines.

(Chapter No. 4): This chapter is divided into 2 parts

A. Companies given above Sales Share (percentage) in Disease Wise Break up & Forecast

B. Adult Vaccines given above Companies Share and Forecast

(Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these vaccines have been further sub-divided into 4 parts

A. Adult Vaccine Market & Forecast|

B. Number of Adults Being Vaccinated & Forecast

C. Number of Adult Vaccines Doses & Forecast

D. Number of Cases

(Chapter 6): This chapter studies mentioned above all the 5 companies Adult Vaccines Sales and Forecast. The chapter further talks about the Company alliances with other Companies in order to increase their vaccine sales.

(Chapter 7): This chapter studies mentioned above all the 5 companies’ Sales and Forecast Disease Wise

(Chapter 8): This chapter provides Adult Vaccines Market and Forecast data of 8 Geographic Regions Worldwide.

1. United States

2. North America/Caribbean

3. South America

4. Europe

5. Japan

6. India

7. China

8. Rest of the World (ROW)

(Chapter 9): This chapter comprises of important Mergers and Acquisitions happening in the field of vaccines

(Chapter 10): This chapter studies growth Factors Driving the Adult Vaccines Market. In total 8 growth topics have been discussed in this chapter.

(Chapter 11): This chapter studies Challenges/Hindrances faced by Adult Vaccines Market. In total 7 challenges topics have been discussed in this chapter

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Comprehensive Table of Contents and more for the report “Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines – Worldwide Analysis” is available at http://www.rnrmarketresearch.com/adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-market-report.html .

About Us:

RnR Market Research is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details on sales@rnrmarketresearch.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need.

Media Contact: Priyank Tiwari, RnR Market Research, + 1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RnR Market Research


Source: PR Newswire



comments powered by Disqus